REQUEST A DEMO
Total
USD $0.00
Search more companies

Luye Pharma Group Ltd (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Luye Pharma Group Ltd Profile Updated: July 09, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English Download a sample report

Luye Pharma Group Ltd operates as an investment holding company principally engaged in the development, production, marketing and sale of pharmaceutical products. The company operates through its four segments including : research, development, production and sale of pharmaceutical drugs for the fields of orthopaedics, neurology, gastroenterology and hepatology, focusing on natural drugs and chemical drugs with new formulations; distribution of products of other pharmaceutical manufacturers in China; processing and sale of active ingredients, mainly chondroitin sulphate, for the manufacture of pharmaceutical drugs; sale of R&D results and/or patents of new drugs and provision of research services on a contract basis. Luye Pharma Group Ltd was delisted from Singapore Stock Exchange on 6 November 2012. The company was listed in Hong Kong. Luye Pharma Group Ltd was incorporated in 2003 and is based in Singapore.

Legal Address
No. 15 Chuang Ye Road,High-Tech Industrial Development Zone,Yantai, Shandong
Heze; Shandong; Postal Code: 264003

Contact Details: Purchase the Luye Pharma Group Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Luye Pharma Group Ltd report to view the information.
Financial Auditors:
Purchase the Luye Pharma Group Ltd report to view the information.
Incorporation Date:
July 02, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Purchase this report to view the information.
Board Member
Ownership Details
Purchase this report to view the information.
46.32%
Subsidiaries
ABPL
100%
AsiaPharm Investments (Bermuda)
100%
Luye Pharma Investments
100%
Company Performance
Financial values in the chart are available after Luye Pharma Group Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
35.61%
Total operating revenue
33.82%
Operating profit (EBIT)
41.53%
EBITDA
38.33%
Net Profit (Loss) for the Period
33.19%
Total assets
62.99%
Total equity
15.05%
Operating Profit Margin (ROS)
1.25%
Net Profit Margin
-0.46%
Return on Equity (ROE)
2.24%
Debt to Equity Ratio
36.61%
Quick Ratio
-0.62%
Cash Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?